Sinco Pharmaceuticals Holdings Limited

SEHK:6833 株式レポート

時価総額:HK$370.0m

Sinco Pharmaceuticals Holdings マネジメント

マネジメント 基準チェック /34

Sinco Pharmaceuticals Holdingsの CEO はMin Jinで、 Mar2023年に任命され、 の在任期間は 1.67年です。 の年間総報酬はCN¥ 1.96Mで、 94.6%給与と5.4%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.67%を直接所有しており、その価値はHK$ 2.49M 。経営陣と取締役会の平均在任期間はそれぞれ1.8年と6年です。

主要情報

Min Jin

最高経営責任者

CN¥2.0m

報酬総額

CEO給与比率94.6%
CEO在任期間1.7yrs
CEOの所有権0.7%
経営陣の平均在職期間1.8yrs
取締役会の平均在任期間6yrs

経営陣の近況

Recent updates

Lacklustre Performance Is Driving Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 26% Price Drop

Nov 20
Lacklustre Performance Is Driving Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 26% Price Drop

What Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 32% Share Price Gain Is Not Telling You

Oct 04
What Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 32% Share Price Gain Is Not Telling You

Risks To Shareholder Returns Are Elevated At These Prices For Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Aug 16
Risks To Shareholder Returns Are Elevated At These Prices For Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Some Investors May Be Willing To Look Past Sinco Pharmaceuticals Holdings' (HKG:6833) Soft Earnings

Apr 02
Some Investors May Be Willing To Look Past Sinco Pharmaceuticals Holdings' (HKG:6833) Soft Earnings

Sinco Pharmaceuticals Holdings Limited (HKG:6833) Might Not Be As Mispriced As It Looks

Mar 08
Sinco Pharmaceuticals Holdings Limited (HKG:6833) Might Not Be As Mispriced As It Looks

Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

Nov 07
Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

A Look At The Intrinsic Value Of Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Jun 26
A Look At The Intrinsic Value Of Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

May 30
Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

Sinco Pharmaceuticals Holdings (HKG:6833) Has A Pretty Healthy Balance Sheet

Oct 26
Sinco Pharmaceuticals Holdings (HKG:6833) Has A Pretty Healthy Balance Sheet

Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Might Deserve Your Attention Today

Feb 04
Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Might Deserve Your Attention Today

I Ran A Stock Scan For Earnings Growth And Sinco Pharmaceuticals Holdings (HKG:6833) Passed With Ease

Oct 25
I Ran A Stock Scan For Earnings Growth And Sinco Pharmaceuticals Holdings (HKG:6833) Passed With Ease

Little Excitement Around Sinco Pharmaceuticals Holdings Limited's (HKG:6833) Earnings

Jun 10
Little Excitement Around Sinco Pharmaceuticals Holdings Limited's (HKG:6833) Earnings

Sinco Pharmaceuticals Holdings (HKG:6833) Could Easily Take On More Debt

May 24
Sinco Pharmaceuticals Holdings (HKG:6833) Could Easily Take On More Debt

Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Is An Interesting Stock

Apr 20
Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Is An Interesting Stock

We're Not So Sure You Should Rely on Sinco Pharmaceuticals Holdings' (HKG:6833) Statutory Earnings

Feb 16
We're Not So Sure You Should Rely on Sinco Pharmaceuticals Holdings' (HKG:6833) Statutory Earnings

How Much Did Sinco Pharmaceuticals Holdings'(HKG:6833) Shareholders Earn From Share Price Movements Over The Last Three Years?

Jan 11
How Much Did Sinco Pharmaceuticals Holdings'(HKG:6833) Shareholders Earn From Share Price Movements Over The Last Three Years?

Should You Be Excited About Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 51% Return On Equity?

Dec 07
Should You Be Excited About Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 51% Return On Equity?

CEO報酬分析

Sinco Pharmaceuticals Holdings の収益と比較して、Min Jin の報酬はどのように変化したか?
日付総報酬給与会社業績
Jun 30 2024n/an/a

CN¥47m

Mar 31 2024n/an/a

CN¥44m

Dec 31 2023CN¥2mCN¥2m

CN¥42m

Sep 30 2023n/an/a

CN¥35m

Jun 30 2023n/an/a

CN¥27m

Mar 31 2023n/an/a

CN¥48m

Dec 31 2022CN¥2mCN¥2m

CN¥69m

報酬と市場: Minの 総報酬 ($USD 270.53K ) は、 Hong Kong市場 ($USD 232.62K ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Minの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Min Jin (46 yo)

1.7yrs

在職期間

CN¥1,959,000

報酬

Mr. Min Jin is Chief Accountant since August 17, 2023 and Secretary since December 21, 2023 at Nanjing Tanker Corporation. He was Co-Chief Executive Officer at Sinco Pharmaceuticals Holdings Limited since...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Xiangbin Huang
Executive Chairman13.6yrsCN¥7.10m51.65%
HK$ 191.1m
Min Jin
Chief Executive Officer1.7yrsCN¥1.96m0.67%
HK$ 2.5m
Shifeng Lei
Executive Directorno dataCN¥1.09mデータなし
Yifan Li
Chief Financial Officer9.4yrsデータなしデータなし
Zhijian Huang
Executive Directorless than a yearデータなしデータなし
Yunlu Peng
Company Secretary5.1yrsデータなしデータなし
Tao Zhang
President of Sichuan Sinco Pharmaceuticals Co. Ltd.2yrsデータなしデータなし

1.8yrs

平均在職期間

44yo

平均年齢

経験豊富な経営陣: 6833の経営陣は 経験豊富 とはみなされません ( 1.8年の平均在職年数)。これは新しいチームを示唆しています。


取締役

名称ポジション在職期間報酬所有権
Xiangbin Huang
Executive Chairman13.6yrsCN¥7.10m51.65%
HK$ 191.1m
Shifeng Lei
Executive Director1.7yrsCN¥1.09mデータなし
Zhijian Huang
Executive Directorless than a yearデータなしデータなし
Ying Kit Lau
Independent Non-Executive Director6yrsCN¥300.00kデータなし
Wenfang Liu
Independent Non-Executive Director8.8yrsCN¥300.00kデータなし
Qing Wang
Independent Non-Executive Director8.8yrsCN¥300.00kデータなし
Zhizhong Bai
Independent Non-Executive Director4.2yrsCN¥300.00kデータなし

6.0yrs

平均在職期間

58yo

平均年齢

経験豊富なボード: 6833の 取締役会経験豊富 であると考えられます ( 6年の平均在任期間)。